Across TCGA pan-cancer cohorts, PTMAP15 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PTMAP15’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where PTMAP15 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PTMAP15 is over-expressed in tumor.
LUAD and HNSC are the cancer types where PTMAP15 tumor–normal differential expression is most reproducible.